SARS_CoV_2 mutation literature information.


  High-resolution melting analysis after nested PCR for the detection of SARS-CoV-2 spike protein G339D and D796Y variations.
 PMID: 35349821       2022       Biochemical and biophysical research communications
Introduction: reported the detection of D614G (nucleotide mutation: A23403G) and L452R (nucleotide mutation: T22917G) variations in the SARS-CoV-2 spike protein by post-PCR HRM analysis, respectively.
Discussion: In the case of detection for the D614G variation (mutation A23403G) reported by Gazali et al., the difference in the Tm value was 0.23 C.


  AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2.
 PMID: 35346184       2022       BMC medicine
Abstract: The anti-RBD IgG antibodies from these vaccinated individuals were broadly cross-reactive against multiple VOCs and had neutralisation potency against original D614G, beta, and delta variants.
Figure: D Magnitude of neutralisation activity against the beta, D614G, and delta variants in pre- and post-vaccination sera.
Figure: E Number of individuals with neutralisation activity against Beta or D614G or Delta variants in pre- and post-vaccination sera.

Browser Board

 Co-occurred Entities




   Filtrator